Differences in the substrate binding sites of murine and human proteinase 3 and neutrophil elastase

FEBS Letters

Volumn 581, Issue 29, 2007, Pages 5685-5690

  Hajjar, Eric ^a,b   Korkmaz, Brice ^c   Reuter, Nathalie ^a  

^a BCCS   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

Author keywords

Inflammation; Molecular dynamics simulations; Murine models; Neutrophil; Neutrophil elastase; PR3

Indexed keywords

LEUKOCYTE ELASTASE; MYELOBLASTIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; ENZYME ANALYSIS; ENZYME BINDING; ENZYME STRUCTURE; ENZYME SUBSTRATE; ENZYME SUBSTRATE COMPLEX; HUMAN VERSUS ANIMAL COMPARISON; MOLECULAR DYNAMICS; MOLECULAR MODEL; PREDICTION; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN MOTIF; SIMULATION; SURFACE PROPERTY;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; COMPUTER SIMULATION; HUMANS; LEUKOCYTE ELASTASE; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MYELOBLASTIN; SUBSTRATE SPECIFICITY; SURFACE PROPERTIES;

MURINAE;

EID: 36549053594     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.11.029     Document Type: Article

References (31)

1. Pham C.T. Neutrophil serine proteases: specific regulators of inflammation. Nat. Rev. Immunol. 6 (2006) 541-550
2. Owen C.A., and Campbell E.J. The cell biology of leukocyte-mediated proteolysis. J. Leukoc. Biol. 65 (1999) 137-150
3. Campbell E.J., Campbell M.A., Boukedes S.S., and Owen C.A. Quantum proteolysis by neutrophils: implications for pulmonary emphysema in alpha 1-antitrypsin deficiency. J. Clin. Invest. 104 (1999) 337-344
4. Witko-Sarsat V., et al. A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J. Am. Soc. Nephrol. 10 (1999) 1224-1233
5. Witko-Sarsat V., Cramer E.M., Hieblot C., Guichard J., Nusbaum P., Lopez S., Lesavre P., and Halbwachs-Mecarelli L. Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules. Blood 94 (1999) 2487-2496
6. E. Hajjar, M. Mihajlovic, V. Witko-Sarsat, T. Lazaridis, and N. Reuter, in press. Computational prediction of the binding site of Proteinase3 to the plasma membrane. Proteins: Structure, Function, and Bioinformatics, in press.
7. Witko-Sarsat V., Canteloup S., Durant S., Desdouets C., Chabernaud R., Lemarchand P., and Descamps-Latscha B. Cleavage of p21wafl by proteinase-3, a myeloid-specific serine protease, potentiates cell proliferation. J. Biol. Chem. 277 (2002) 47338-47347
8. Pederzoli M., Kantari C., Gausson V., Moriceau S., and Witko-Sarsat V. Proteinase-3 induces procaspase-3 activation in the absence of apoptosis: potential role of this compartmentalized activation of membrane-associated procaspase-3 in neutrophils. J. Immunol. 174 (2005) 6381-6390
9. Shapiro S.D., Goldstein N.M., Houghton A.M., Kobayashi D.K., Kelley D., and Belaaouaj A. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am. J. Pathol. 163 (2003) 2329-2335
10. Belaaouaj A., McCarthy R., Baumann M., Gao Z., Ley T.J., Abraham S.N., and Shapiro S.D. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat. Med. 4 (1998) 615-618
11. Pfister H., Ollert M., Frohlich L.F., Quintanilla-Martinez L., Colby T.V., Specks U., and Jenne D.E. Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood 104 (2004) 1411-1418
12. Jenne D.E., Frohlich L., Hummel A.M., and Specks U. Cloning and functional expression of the murine homologue of proteinase 3: implications for the design of murine models of vasculitis. FEBS Lett. 408 (1997) 187-190
13. Wiesner O., Litwiller R.D., Hummel A.M., Viss M.A., McDonald C.J., Jenne D.E., Fass D.N., and Specks U. Differences between human proteinase 3 and neutrophil elastase and their murine homologues are relevant for murine model experiments. FEBS Lett. 579 (2005) 5305-5312
14. Hedstrom L. Serine protease mechanism and specificity. Chem. Rev. 102 (2002) 4501-4524
15. Kam C.M., Kerrigan J.E., Dolman K.M., Goldschmeding R., Von dem Borne A.E., and Powers J.C. Substrate and inhibitor studies on proteinase 3. FEBS Lett. 297 (1992) 119-123
16. Korkmaz B., Attucci S., Hazouard E., Ferrandiere M., Jourdan M.L., Brillard- Bourdet M., Juliano L., and Gauthier F. Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates. J. Biol. Chem. 277 (2002) 39074-39081
17. Koehl C., Knight G., and Bieth J. Compared action of neutrophil proteinase 3 and elastase on model substrates. Favorable effect of S′-P′ interactions on proteinase 3 catalysts. J. Biol. Chem. 278 (2003) 12609-12612
18. Korkmaz B., Attucci S., Moreau T., Godat E., Juliano L., and Gauthier F. Design and use of highly specific substrates of neutrophil elastase and proteinase 3. Am. J. Respir. Cell Mol. Biol. 30 (2004) 801-807
19. Hajjar E., Korkmaz B., Gauthier F., Brandsdal B.O., Witko-Sarsat V., and Reuter N. Inspection of the binding sites of proteinase3 for the design of a highly specific substrate. J. Med. Chem. 49 (2006) 1248-1260
20. Korkmaz B., Hajjar E., Kalupov T., Reuter N., Brillard-Bourdet M., Moreau T., Juliano L., and Gauthier F. Influence of charge distribution at the active site surface on the substrate specificity of human neutrophil protease 3 and elastase. A kinetic and molecular modeling analysis. J. Biol. Chem. 282 (2007) 1989-1997
21. Schechter I., and Berger A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27 (1967) 157-162
22. Dublet B., Ruello A., Pederzoli M., Hajjar E., Courbebaisse M., Canteloup S., Reuter N., and Witko-Sarsat V. Cleavage of p21/WAFl/CIPl by proteinase 3 modulates differentiation of a monocytic cell line. Molecular analysis of the cleavage site. J. Biol. Chem. 280 (2005) 30242-30253
23. Tramontano A. The role of molecular modelling in biomedical research. FEBS Lett. 580 (2006) 2928-2934
24. Sali A., and Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234 (1993) 779-815
25. Dundas J., Ouyang Z., Tseng J., Binkowski A., Turpaz Y., and Liang J. CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic. Acids Res. 34 (2006) W116-W118
26. Nicholls A., Sharp K.A., and Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11 (1991) 281-296
27. Brooks B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S., and Karplus M. CHARMM: A Program for Macromolecular Energy, Minimization, and Dynamics Calculations. J. Comput. Chem. 4 (1983) 187-217
28. Kale L., et al. NAMD2: greater scalability for parallel molecular dynamics. J. Comp. Phys. 151 (1999) 283-312
29. Briggs, J.M. et al. 1993. Program. University of Houston Brownian Dynamics (UHBD).
30. Schaefer M., Sommer M., and Karplus M. pH-dependence of protein stability: absolute electrostatic free energy differences between conformations. J. Phys. Chem. B 101 (1997) 1663-1683
31. MacKerell A.D., et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B 102 (1998) 3586-3616